3D ultra-low-dose CT 'Claripulmo' jointly developed by a domestic company and Seoul National University Hospital, recently approved by the US and European FDA
ConcertAI’s TeraRecon Partners with ClariPi
https://www.prnewswire.com/news-releases
ClariPi Joins Siemens Healthineers Digital Marketplace
https://www.prnewswire.com/news-releases
https://marketplace.teamplay.siemens-healthineers.com
ClariPi’s Joins Bayer’s Calantic – Breast Density Measurement Solution
https://www.bayer.com/media/en-us/
ClariPi will be at ROKO from May 8th – 10th, 2024 at Rhein Main Congress Center in Germany (Booth: Süd 07). If you are interested in our products, you could visit our booth or arrange a demo session online. Just message us to schedule a meeting! Thank you!